Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over prasugreL: a mUlticenter Randomized Open-label Trial in patientS With ST-elevation Myocardial inFarction Referred for primAry percutaneouS inTERvention.FABOLUS FASTER Trial
Phase of Trial: Phase IV
Latest Information Update: 21 Sep 2017
At a glance
- Drugs Cangrelor (Primary) ; Prasugrel (Primary) ; Tirofiban (Primary)
- Indications Coronary artery disease; Myocardial infarction
- Focus Pharmacodynamics
- Acronyms FABOLUS-FASTER
- 18 Sep 2017 Planned End Date changed from 1 Apr 2018 to 1 Jul 2018.
- 18 Sep 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Jul 2018.
- 18 Sep 2017 Status changed from not yet recruiting to recruiting.